RN7SL266P

Across TCGA pan-cancer cohorts, RN7SL266P RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated RN7SL266P data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher RN7SL266P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RN7SL266P expression acts as an unfavorable survival marker.

BLCA, HNSC, and OV are the cancer types where RN7SL266P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Tertile	All	0.345	0.715	<.001	198	view →
HNSC	OS	Tertile	IV	0.001	0.643	<.001	126	view →
OV	OS	Tertile	IV	0.241	0.776	<.001	84	view →
CESC	OS	Tertile	All	0.047	0.875	<.001	72	view →
KIRC	DFS	Tertile	IV	0.124	0.649	<.001	60	view →
LUAD	OS	Tertile	II,III,IV	0.315	0.691	.001	60	view →
READ	DFS	Tertile	IV	0.255	0.628	.020	9	view →
PRAD	DFS	Tertile	All	0.799	0.936	.031	6	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

RN7SL266P–BLCA (OS)

Open the BLCA breakdown →